3Davis MP,Walsh D.Epidemiology of cancer pain and factors influencing poor pain control.Am J Hosp Palliat Care,2004,21:137-142.
4Kalso E,Vainio A.Morphine and oxycodone hydrochloride in the management of cancer pain.Clin Pharmacol Ther,1990,47:639-646.
5Finkel JC,Finley A,Greco C.Transdermal fentanyl in the management of children with chronic severe pain:results from an international study.Cancer,2005,104:2847-2857.
6Skaer TL.Transdermal opioids for cancer pain.Health Qual Life Outcomes,2006,4:24.
7Hanna M,Tuca A,Thipphawong J,et al.An open-label,1-year extension study of the longterm safety and efficacy of once-daily OROS.hydromorphone in patients with chronic cancer pain.BMC Palliat Care,2009,8:14.
8Carter NJ,Keating GM.OROS hydromorphone prolonged release:a review of its use in the management of chronic,moderate to severe pain.CNS Drugs,2010,24:337-361.
9Mercadante S,Casuccio A,Fulfaro F,et al.Switching from morphine to methadone to improve analgesia and tolerability in cancer patients.A prospective study.J Clin Oncol,2001,19:2898-2904.
10Rosenthal NR,Silverfield JC,Wu SC,et al.Tramadol/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population.J Am Geriatr Soc,2004,52:374-380.
2Frick E, Panzer M.Depression and quality of life of cancer patientsand going radiation therapy: a cross-sectional study in a community hospital outpatient center[J].European Journal Cancer, 2007, 12 ( 456 ) : 4521-4526.
